AssetMark Inc’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $665K | Buy |
21,250
+1,316
| +7% | +$41.2K | ﹤0.01% | 998 |
|
|
2025
Q1 | $669K | Sell |
19,934
-1,651
| -8% | -$55.4K | ﹤0.01% | 930 |
|
|
2024
Q4 | $846K | Buy |
21,585
+1,915
| +10% | +$75.1K | ﹤0.01% | 877 |
|
|
2024
Q3 | $774K | Buy |
19,670
+1,435
| +8% | +$56.5K | ﹤0.01% | 828 |
|
|
2024
Q2 | $711K | Buy |
18,235
+5,050
| +38% | +$197K | ﹤0.01% | 824 |
|
|
2024
Q1 | $568K | Buy |
13,185
+3,247
| +33% | +$140K | ﹤0.01% | 812 |
|
|
2023
Q4 | $458K | Buy |
9,938
+2,835
| +40% | +$131K | ﹤0.01% | 802 |
|
|
2023
Q3 | $243K | Buy |
7,103
+1,258
| +22% | +$43K | ﹤0.01% | 845 |
|
|
2023
Q2 | $225K | Buy |
+5,845
| New | +$225K | ﹤0.01% | 827 |
|